Cargando...
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
AIM: To investigate the factors influenced the efficacy of tolvaptan (TLV) in liver cirrhosis. METHODS: We retrospectively enrolled 61 consecutive patients with refractory hepatic ascites. All of them had been treated with furosemide and spironolactone before admission, and treated with TLV for 7 d...
Gardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5550787/ https://ncbi.nlm.nih.gov/pubmed/28839438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i29.5379 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|